A Major League Comeback Story: Drew Smith Signs with the Nationals After Injury Battle
In a move that’s sure to spark conversations among baseball fans, the Washington Nationals have inked right-handed pitcher Drew Smith to a minor league deal, as first reported by Michelle Margaux of SNY Sports. But here’s where it gets intriguing: Smith, a Roc Nation Sports client, stands to earn a base salary of $1.75 million if he secures a spot on the big-league roster. And this is the part most people miss—he could pocket an additional $1.25 million through performance bonuses, turning this into a potentially lucrative comeback story.
Smith’s journey to the Nationals hasn’t been without its hurdles. After missing the entire 2025 season due to Tommy John surgery—his second such procedure—the New York Mets declined his $2 million club option for 2026, pushing him into free agency. Despite these setbacks, the 32-year-old has a proven track record, boasting a 3.48 ERA across 191 MLB games since his debut in 2018. His 2024 season with the Mets was shaping up to be his best yet, with a career-high 29.1% strikeout rate over 17 2/3 innings and an ERA just above 3.00. However, his season was cut short by the elbow surgery, leaving fans to wonder what could have been.
But here’s the controversial part: While Smith’s cutter emerged as a dominant pitch in 2024, boasting a 35.8% whiff rate and boosting his swinging-strike rate to 14.3%, his four-seam fastball averaged under 95 mph for the first time in his career. With no rehab assignments last season, questions linger about his velocity post-surgery. Is this a red flag, or can Smith reclaim his form? The Nationals are betting on the latter, especially given their bullpen struggles last season—they ranked dead last in bullpen ERA by a significant margin.
Smith joins a crowded field of non-roster invitees vying for a bullpen spot in Spring Training, including Trevor Gott, Cionel Perez, and Zach Penrod. The departure of reliable reliever Jose A. Ferrer, traded to Seattle for catching prospect Harry Ford, leaves a void that Smith could fill—if he’s healthy. And that’s the million-dollar question: Can he stay injury-free and return to his pre-surgery dominance?
This signing isn’t just about adding depth; it’s a high-stakes gamble on a player with something to prove. For Smith, it’s a chance to rewrite his narrative. For the Nationals, it’s an opportunity to bolster a struggling bullpen with a seasoned arm. But will it pay off? Only time will tell. What do you think—is this a smart move for the Nationals, or are they taking too big a risk? Let us know in the comments!
